Charité - Universitätsmedizin Berlin
A protein enables cardiovascular risk assessment
Researchers at the Charité – Universitätsmedizin Berlin have managed to predict the probability of a cardiovascular patient suffering a heart attack, stroke or arterial occlusion within three months. In the long-term, ...
Cardiology
Apr 04, 2013 |
not rated yet |
0
The immune system can delay healing of bone fractures
(Medical Xpress)—Researchers at Charité – Universitätsmedizin Berlin have succeeded in demonstrating an association between delayed bone fracture healing and increased concentration of specific immune cells in the blood ...
Medical research
Mar 22, 2013 |
not rated yet |
0
Scientists improve arthritis treatments: Rheumatism patients can hope for a new therapy
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité – Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis ...
Arthritis & Rheumatism
Feb 14, 2013 |
5 / 5 (1) |
0
Nanotechnology against pollen allergy
Scientists at the Charité – Universitätsmedizin Berlin have now been able to identify the grass pollen molecule, against which the allergic response of hay fever in children is initiated. In addition, it was shown that ...
Immunology
Feb 11, 2013 |
5 / 5 (1) |
0
Beginning in the womb: Lifestyle of mother shapes disposition for child's subsequent weight
A disposition to be overweight is shaped even before birth. This has been proven by scientists of the Charité – Universitätsmedizin Berlin in an international study, which has appeared in the professional journal Plos On ...
Health
Jan 10, 2013 |
not rated yet |
0
A new promising approach in the therapy of pain
The treatment of inflammatory pain can be improved by endogenous opioid peptides acting directly in injured tissue. Scientists at the Charité – Universitätsmedizin Berlin and the Université Paris Descartes showed that ...
Medical research
Dec 04, 2012 |
5 / 5 (2) |
0
Using antibodies against immune deficiency
Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication ...
Arthritis & Rheumatism
Sep 27, 2012 |
not rated yet |
0
Self-regulating networks dictate the genetic program of tumor cells
Scientists at Charité – Universitätsmedizin Berlin could explain a yet unknown regulatory network that controls the growth of tumor cells. Understanding such networks is an important task in molecular tumor biology in ...
Cancer
Sep 25, 2012 |
not rated yet |
0
Structural and functional abnormalities found in brains of relapsed alcohol-dependent patients
Scientists at Charité – Universitätsmedizin Berlin have succeeded in coming closer to determining the risk of relapse in detoxified alcohol-dependent patients. Using an imaging process (magnetic resonance tomography) ...
Psychology & Psychiatry
Sep 20, 2012 |
not rated yet |
0
Molecular signature of hantavirus infection in humans decoded
German scientists at Charité – Universitätsmedizin Berlin and Labor Berlin GmbH have succeeded in clarifying the molecular signature of the viruses that lead to an increasing size and number of hantavirus outbreaks in ...
Diseases, Conditions, Syndromes
Sep 03, 2012 |
not rated yet |
0
